首页> 外国专利> CELL PERMEABLE NANOCONJUGATES OF SHELL-CROSSLINKED KNEDEL (SCK) AND PEPTIDE NUCLEIC ACIDS ('PNAs') WITH UNIQUELY EXPRESSED OR OVER-EXPRESSED mRNA TARGETING SEQUENCES FOR EARLY DIAGNOSIS AND THERAPY OF CANCER

CELL PERMEABLE NANOCONJUGATES OF SHELL-CROSSLINKED KNEDEL (SCK) AND PEPTIDE NUCLEIC ACIDS ('PNAs') WITH UNIQUELY EXPRESSED OR OVER-EXPRESSED mRNA TARGETING SEQUENCES FOR EARLY DIAGNOSIS AND THERAPY OF CANCER

机译:壳聚糖交联的KNEDEL(SCK)和肽核酸(“ PNAs”)的细胞可渗透的纳米缀合物,具有用于早期诊断和癌症治疗的独特表达或过表达的mRNA靶向序列

摘要

A functional biologically active particle conjugate useful for diagnosis and treating cancer as a bioportal comprises a nanoscale particle having associated therewith an intracellular targeting ligand comprising a PNA, or another nuclease resistant oligonucleotide analog such as MOE-mRNA (2′-methoxyethyl mRNA) or LNA (locked nucleic acid), having a sequence that binds selectively to an uniquely expressed or overexpressed mRNA specific to the cancer or disease state in a living mammal. In one aspect the uniquely overexpressed target specific to the cancer or disease state is the unr mRNA which can be targeted by the antisense sequence PNA50.
机译:可作为生物门用于诊断和治疗癌症的功能性生物活性颗粒共轭物,包括与纳米级颗粒相关联的纳米级颗粒,该细胞内靶向配体包含PNA或另一种抗核酸酶的寡核苷酸类似物,例如MOE-mRNA(2'-甲氧基乙基mRNA)或LNA (锁定的核酸),具有与活体哺乳动物的癌症或疾病状态特异的独特表达或过表达的mRNA选择性结合的序列。一方面,特异于癌症或疾病状态的独特的过表达靶标是可以由反义序列PNA50靶向的unr mRNA。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号